Are standardized conditions needed for correct CGM data interpretation in subjects at early stages of glucose intolerance?
Aim The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. Methods an...
Saved in:
| Published in | Diabetology and metabolic syndrome Vol. 17; no. 1; pp. 29 - 9 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
22.01.2025
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1758-5996 1758-5996 |
| DOI | 10.1186/s13098-025-01579-x |
Cover
| Abstract | Aim
The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes.
Methods and results
Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m
2
), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m
2
), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m
2
), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods.
Conclusion
The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. |
|---|---|
| AbstractList | The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes.AIMThe present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes.Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m2), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m2), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m2), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods.METHODS AND RESULTSSeventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m2), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m2), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m2), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods.The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population.CONCLUSIONThe trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. Abstract Aim The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. Methods and results Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m2), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m2), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m2), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods. Conclusion The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m.sup.2), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m.sup.2), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m.sup.2), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods. The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m ), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m ), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m ), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods. The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. Aim The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. Methods and results Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m.sup.2), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m.sup.2), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m.sup.2), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods. Conclusion The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. Keywords: Early glucose intolerance, Continuous glucose monitoring, Glucose variability, Standard conditions Aim The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes. Methods and results Seventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m 2 ), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m 2 ), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m 2 ), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods. Conclusion The trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. AimThe present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard conditions for a 24-h period and under usual everyday conditions for a 14-day period in a high-risk population without diabetes.Methods and resultsSeventy five subjects: 14 with normal glucose tolerance (NGT; mean age 43.6 ± 10.7 years; BMI 30.5 ± 6.9 kg/m2), 19 with high 1-h postload glucose > 8.6 mmol/l (1hrOGTT; mean age 45.6 ± 8.9 years; BMI 33.7 ± 6.9 kg/m2), and 42 with isolated impaired glucose tolerance (iIGT; mean age 47.6 ± 11.8 years; BMI 31.0 ± 6.5 kg/m2), were enrolled. An OGTT was performed. CGM was performed with blinded FreeStyleLibrePro for 24 h under standard conditions and for the rest of the 14-day period under usual everyday conditions. GV parameters derived from both periods were compared. There was a significant increase in GV with worsening of glucose tolerance from NGT, to 1hrOGTT and iIGT, independently of the conditions. Our findings showed moderate to strong correlations among GV indices between the studied periods in the cohort and in the 1hrOGTT and iIGT groups. However, a significant difference was found in some of the GV parameters between the analyzed periods.ConclusionThe trend in GV is independent of the conditions, under which CGM is performed, in subjects at early stages of glucose intolerance. Although its measurements to some extend differ in standard and everyday conditions, there is no need of standardized conditions for correct interpretation of GV indices in this population. |
| ArticleNumber | 29 |
| Audience | Academic |
| Author | Chakarova, N. Tankova, T. Dimova, R. |
| Author_xml | – sequence: 1 givenname: R. surname: Dimova fullname: Dimova, R. email: dr.roumyana.dimova@gmail.com organization: Department of Endocrinology, Medical University of Sofia – sequence: 2 givenname: N. surname: Chakarova fullname: Chakarova, N. organization: Department of Endocrinology, Medical University of Sofia – sequence: 3 givenname: T. surname: Tankova fullname: Tankova, T. organization: Department of Endocrinology, Medical University of Sofia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39844273$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUl1v0zAUjdAQ-4A_wAOKhIR4ybCT-OtpqioYk4Z4gWfrxrlJU6V2sZOx7tfjtGVrEUIoD46vzzn2PeeeJyfWWUyS15RcUir5h0ALomRGcpYRyoTK7p8lZ1QwmTGl-MnB_2lyHsKSEC6YKF8kp4WSZZmL4ix5mHlMwwC2Bl93D1inxtm6GzpnQ2oR61hpnI9V79EM6fz6S1rDAGlnB_RrjwNM2LhNw1gtIySkMKQIvt9Mui2G1DVp24_GBZxYrkcP1uDVy-R5A33AV_v1Ivn-6eO3-efs9uv1zXx2mxmWkyHjCplknLO4YoUKmia2BKUAIQxrCk6gUlQpQXPKc4mkMCUFU0nDsSxZUVwkNzvd2sFSr323Ar_RDjq9LTjfavBDZ3rUhHFGODFQRS5XBJBwilKWQsRbZR61ip3WaNew-Ql9_yhIiZ5S0btUdExFb1PR95F1tWOtx2qFtUE7eOiPnnJ8YruFbt3dJKhUWbCo8H6v4N2PEcOgV10w2Pdg0Y1BF5RJwctS0Qh9-wd06UZvo8O6yOOLFM1V_oRqIfbd2cbFi80kqmcyL5lUUk7WXf4FFb8aV10cFGy6WD8ivDsgLBD6YRFcP27n6Rj45tCSRy9-T2YE5DuA8S4Ej83_Gb2PJ0SwbdE_9f4P1i9NxQTM |
| Cites_doi | 10.1089/dia.2018.0150 10.1007/s00125-014-3390-x 10.1055/s-2007-979906 10.1111/j.1464-5491.2007.02119.x 10.3390/biomedicines12092006 10.2337/dc15-1188 10.1097/CCM.0b013e3181cc4be9 10.2337/diab.19.9.644 10.1016/j.diabet.2019.101118 10.1016/j.diabres.2019.03.038 10.2337/dc16-1769 10.1177/1932296818790994 10.2337/diabetes.53.4.955 10.1177/1932296817710478 10.1186/1758-5996-5-38 10.1089/dia.2005.7.253 10.1016/j.cmet.2023.04.002 10.1016/j.ijcard.2016.04.078 10.2337/dc15-2035 10.1016/j.cell.2015.11.001 10.3390/children11080907 10.1016/j.diabres.2024.111589 10.1089/152091503322527021 10.2337/dc08-0225 10.2337/dc19-S002 10.1177/1932296814537039 10.1089/dia.2012.0333 10.1002/dmrr.3531 10.1016/j.diabres.2018.09.017 10.1111/j.0954-6820.1965.tb01810.x 10.1089/dia.2016.0112 10.1038/s41598-023-40949-1 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2025 2025 |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2025 2025 |
| DBID | C6C AAYXX CITATION NPM 3V. 7QP 7TS 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1186/s13098-025-01579-x |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) Physical Education Index ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1758-5996 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_0565060cab6e4690ae061e88477ff582 10.1186/s13098-025-01579-x PMC11899435 A824589883 39844273 10_1186_s13098_025_01579_x |
| Genre | Journal Article |
| GeographicLocations | Bulgaria |
| GeographicLocations_xml | – name: Bulgaria |
| GrantInformation_xml | – fundername: the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria grantid: project № BG-RRP-2.004-0004-C01 – fundername: EFSD grantid: Mentorship programme 2018 – fundername: National science fund - financial support of basic research projects – 2019 grantid: contract КП-06 Н 33/7 from 13.12.2019 – fundername: National science fund - financial support of basic research projects - 2019 grantid: contract КП-06 Н 33/7 from 13.12.2019 |
| GroupedDBID | --- 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ RNS ROL RPM RSV SMD SOJ TUS U2A UKHRP AAYXX CITATION ALIPV NPM PMFND 3V. 7QP 7TS 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM 2VQ ADRAZ ADTOC AHSBF EJD H13 IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c520t-69e5856659e5ebe9aff599a47a77c5f360ab91997121628e03c41acb8c6e44533 |
| IEDL.DBID | M48 |
| ISSN | 1758-5996 |
| IngestDate | Wed Aug 27 01:31:44 EDT 2025 Tue Aug 19 23:42:16 EDT 2025 Tue Sep 30 17:04:57 EDT 2025 Fri Sep 05 00:40:02 EDT 2025 Mon Jun 30 08:30:41 EDT 2025 Tue Jun 17 21:55:56 EDT 2025 Tue Jun 10 20:55:17 EDT 2025 Thu May 22 21:23:33 EDT 2025 Thu Apr 03 06:59:41 EDT 2025 Wed Oct 01 06:40:23 EDT 2025 Sat Sep 06 07:29:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Continuous glucose monitoring Early glucose intolerance Glucose variability Standard conditions |
| Language | English |
| License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. cc-by-nc-nd |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c520t-69e5856659e5ebe9aff599a47a77c5f360ab91997121628e03c41acb8c6e44533 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/0565060cab6e4690ae061e88477ff582 |
| PMID | 39844273 |
| PQID | 3201591292 |
| PQPubID | 54993 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0565060cab6e4690ae061e88477ff582 unpaywall_primary_10_1186_s13098_025_01579_x pubmedcentral_primary_oai_pubmedcentral_nih_gov_11899435 proquest_miscellaneous_3158764491 proquest_journals_3201591292 gale_infotracmisc_A824589883 gale_infotracacademiconefile_A824589883 gale_healthsolutions_A824589883 pubmed_primary_39844273 crossref_primary_10_1186_s13098_025_01579_x springer_journals_10_1186_s13098_025_01579_x |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2025-01-22 |
| PublicationDateYYYYMMDD | 2025-01-22 |
| PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-22 day: 22 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Diabetology and metabolic syndrome |
| PublicationTitleAbbrev | Diabetol Metab Syndr |
| PublicationTitleAlternate | Diabetol Metab Syndr |
| PublicationYear | 2025 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | J Hermanides (1579_CR12) 2010; 38 A Chobot (1579_CR31) 2024; 11 1579_CR22 NR Hill (1579_CR17) 2007; 24 JF Semenova (1579_CR34) 2024; 12 G Acciaroli (1579_CR25) 2018; 12 MA Abdul-Ghani (1579_CR28) 2008; 31 SV Madhu (1579_CR5) 2013; 15 M Bergman (1579_CR30) 2024; 209 A Keshet (1579_CR26) 2023; 35 C Gorst (1579_CR2) 2015; 38 N Chakarova (1579_CR6) 2019; 151 N Ehrhardt (1579_CR8) 2019; 13 L Monnier (1579_CR24) 2017; 40 American Diabetes Association (1579_CR10) 2019; 42 J Schlichtkrull (1579_CR13) 1965; 177 B Kovatchev (1579_CR1) 2016; 39 V Swami (1579_CR33) 2024; 72 EA Ryan (1579_CR15) 2004; 53 W Xu (1579_CR3) 2016; 215 T Chen (1579_CR9) 2013; 5 BP Kovatchev (1579_CR14) 2003; 5 EC Rizos (1579_CR20) 2024; 18 C Cobelli (1579_CR23) 2016; 18 M Matabuena (1579_CR32) 2023; 13 GD Molnar (1579_CR16) 1970; 19 D Zeevi (1579_CR19) 2015; 163 RP Wadwa (1579_CR21) 2018; 20 R Dimova (1579_CR7) 2022; 38 A Alyass (1579_CR29) 2015; 58 JM Wójcicki (1579_CR18) 1995; 27 CM McDonnell (1579_CR11) 2005; 7 S Salkind (1579_CR4) 2014; 8 M Bergman (1579_CR27) 2018; 146 |
| References_xml | – volume: 72 start-page: 18 issue: 1 year: 2024 ident: 1579_CR33 publication-title: J Assoc Physicians India – volume: 20 start-page: 395 year: 2018 ident: 1579_CR21 publication-title: Diabetes Technol Ther doi: 10.1089/dia.2018.0150 – volume: 58 start-page: 87 year: 2015 ident: 1579_CR29 publication-title: Diabetologia doi: 10.1007/s00125-014-3390-x – volume: 27 start-page: 41 issue: 1 year: 1995 ident: 1579_CR18 publication-title: Horm Metab Res doi: 10.1055/s-2007-979906 – volume: 24 start-page: 753 issue: 7 year: 2007 ident: 1579_CR17 publication-title: Diabet Med doi: 10.1111/j.1464-5491.2007.02119.x – volume: 18 start-page: 414 issue: 2 year: 2024 ident: 1579_CR20 publication-title: JDST – volume: 12 start-page: 2006 issue: 9 year: 2024 ident: 1579_CR34 publication-title: Biomedicines doi: 10.3390/biomedicines12092006 – volume: 38 start-page: 2354 issue: 12 year: 2015 ident: 1579_CR2 publication-title: Diabetes Care doi: 10.2337/dc15-1188 – volume: 38 start-page: 838 issue: 3 year: 2010 ident: 1579_CR12 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181cc4be9 – volume: 19 start-page: 644 issue: 9 year: 1970 ident: 1579_CR16 publication-title: Diabetes doi: 10.2337/diab.19.9.644 – ident: 1579_CR22 doi: 10.1016/j.diabet.2019.101118 – volume: 151 start-page: 56 year: 2019 ident: 1579_CR6 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2019.03.038 – volume: 40 start-page: 832 year: 2017 ident: 1579_CR24 publication-title: Diabetes Care doi: 10.2337/dc16-1769 – volume: 13 start-page: 271 issue: 2 year: 2019 ident: 1579_CR8 publication-title: J Diabetes Sci Technol doi: 10.1177/1932296818790994 – volume: 53 start-page: 955 issue: 4 year: 2004 ident: 1579_CR15 publication-title: Diabetes doi: 10.2337/diabetes.53.4.955 – volume: 12 start-page: 105 year: 2018 ident: 1579_CR25 publication-title: J Diabetes Sci Technol doi: 10.1177/1932296817710478 – volume: 5 start-page: 38 year: 2013 ident: 1579_CR9 publication-title: Diabetol Metab Syndr doi: 10.1186/1758-5996-5-38 – volume: 7 start-page: 253 issue: 2 year: 2005 ident: 1579_CR11 publication-title: Diabetes Technol Ther doi: 10.1089/dia.2005.7.253 – volume: 35 start-page: 758 issue: 5 year: 2023 ident: 1579_CR26 publication-title: Cell Metab doi: 10.1016/j.cmet.2023.04.002 – volume: 215 start-page: 263 year: 2016 ident: 1579_CR3 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.04.078 – volume: 39 start-page: 502 issue: 4 year: 2016 ident: 1579_CR1 publication-title: Diabetes Care doi: 10.2337/dc15-2035 – volume: 163 start-page: 1079 year: 2015 ident: 1579_CR19 publication-title: Cell doi: 10.1016/j.cell.2015.11.001 – volume: 11 start-page: 907 issue: 8 year: 2024 ident: 1579_CR31 publication-title: Children doi: 10.3390/children11080907 – volume: 209 year: 2024 ident: 1579_CR30 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2024.111589 – volume: 5 start-page: 817 issue: 5 year: 2003 ident: 1579_CR14 publication-title: Diabetes Technol Ther doi: 10.1089/152091503322527021 – volume: 31 start-page: 1650 year: 2008 ident: 1579_CR28 publication-title: Diabetes Care doi: 10.2337/dc08-0225 – volume: 42 start-page: S13 issue: Supplement 1 year: 2019 ident: 1579_CR10 publication-title: Diabetes Care doi: 10.2337/dc19-S002 – volume: 8 start-page: 1042 issue: 5 year: 2014 ident: 1579_CR4 publication-title: J Diabetes Sci Technol doi: 10.1177/1932296814537039 – volume: 15 start-page: 461 year: 2013 ident: 1579_CR5 publication-title: Diabetes Technol Ther doi: 10.1089/dia.2012.0333 – volume: 38 issue: 5 year: 2022 ident: 1579_CR7 publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.3531 – volume: 146 start-page: 18 year: 2018 ident: 1579_CR27 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2018.09.017 – volume: 177 start-page: 95 year: 1965 ident: 1579_CR13 publication-title: Acta Med Scand doi: 10.1111/j.0954-6820.1965.tb01810.x – volume: 18 start-page: 505 year: 2016 ident: 1579_CR23 publication-title: Diabetes Technol Ther doi: 10.1089/dia.2016.0112 – volume: 13 start-page: 13987 year: 2023 ident: 1579_CR32 publication-title: Sci Rep doi: 10.1038/s41598-023-40949-1 |
| SSID | ssj0067574 |
| Score | 2.3479886 |
| Snippet | Aim
The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under... The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard... Aim The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under... AimThe present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed under standard... Abstract Aim The present study comparatively evaluated glucose variability (GV) parameters derived from both continuous glucose monitoring (CGM) performed... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 29 |
| SubjectTerms | Age Care and treatment Continuous glucose monitoring Diabetes Diabetes mellitus Early glucose intolerance Endocrinology Exercise Glucose intolerance Glucose monitoring Glucose monitors Glucose tolerance Glucose variability Homeostasis Intolerance Medicine Medicine & Public Health Metabolic Diseases Normal distribution Physiological aspects Sensors Standard conditions Variance analysis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDzwOFW8CBYyExIFGdRI7sU_VUlEqpHKiUm-WnUxgpVW22uyqpb-emThJNyABB07R2pNVPN94HsnMmLG3pnZaGyFivPhYZh5iI0DGWaUz9CYI867b55f85Ex-PlfnW0d9UU5YaA8cGHeABpp64JXO50ChnAO0QKBRqRZ1rXSnfdGMDcFU0MHoBRdyKJHR-UGLmppKyVJKVFOFia8mZqjr1v-7Tt4ySr8mTI5fTe-xO5vmwv24dIvFlmE6vs92e4-Sz8JKHrBb0Dxkt0_7b-aP2PVsBXx4YzC_hopjCFyFTC3eoPHCEfRccXRF2o8ffTrllDfK55N8RPzJ242n1zYtd2sO1BmZ_vcbtHxZ8z73ne5aLoCO64DDx-zs-OPXo5O4P3EhLlUq1nFuAMOHPFd4RXSNQxYb42ThiqJUdZYL5w2lpiRpkqcaRFbKxJVelwiORM_xCdtplg08YzwD4YWrvFRQyEpUBnyhUiqLharSXkTs_QCAvQiNNWwXkOjcBrgswmU7uOxVxD4QRiMlNcXuBlBUbC8q9m-iErHXhLANFabj1rYznUqljdZZxN51FLS5EejS9TUKuCRqkzWh3JtQ4qYsp9ODFNleKbQ2Q2dLGXSw8EnejNN0JyW6NbDcIE2i0D5JaZKIPQ1CNy46M1pKdDcjpifiOOHKdKaZf-9ahiNbjUHPOGL7g-TePNef2L4_Svc_oPT8f6D0gt1Nw0aN03SP7axXG3iJjt_av-r2-E-nWFGX priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB5BkXgcEG8CBYyExIFGTRw7sU_VUlEqpHKi0t4sO3HalVbJstkVpb-embzagFRximI7D3ten-2ZMcAHXVqldBSFeHGhSJwPdeRFmBQqQTRBNG-zfX5Pj0_Ft7mc9wtuTe9WOejEVlEXdU5r5PsJWiqp0Trxg9XPkE6Not3V_giN23AnRqhCXJ3NxwkXYuFMDIEyKt1vUF9TQBkndzWZ6fBiYozanP3_auZrpulvt8lx7_QB3NtWK_v7l10ur5mno0fwsMeVbNYxwmO45asncPek3zl_CpeztWfDusHi0hcMJ8JF56_FKjRhWIL4FUvXpAPZ4dcTRt6jbDHxSsRb1mwdLd40zG6Yp_zI9N4z37C6ZL0HPD1VLz0d2uEPnsHp0Zcfh8dhf-5CmEsebcJUe5xEpKnEK9JY27KUWluR2SzLZZmkkXWaHFRiHqdc-SjJRWxzp_LUC4H48TnsVHXlXwJLfOQiWzghfSaKqNDeZZJTcKwvCuWiAD4NBDCrLr2GaaclKjUduQySy7TkMhcBfCYajS0pNXZbUK_PTC9pBhEdJU3MrcO_wbm_9QhZPH4xy7AfigfwjihsujjTUcDNTHEhlVYqCeBj24JEHAmd2z5SAbtEybImLXcnLVE082n1wEWmVw2NuWLkAN6P1fQkubtVvt5im1iilRJCxwG86Jhu7HSilRAIOgNQE3acjMq0plqct4nDcVi1RnwcwN7AuVf_ddOw743c_R9UenVzr1_Dfd6JYMj5Luxs1lv_BoHdxr1tpfcPo6VKAg priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQkXgcEG8CBYyExIFGOInt2Ce0rCgVUjlRqTfLTiZlpVW22uyKtr-embzYAEJwiuJHYvubsT_HMxPGXtvKG2OFiPESYpkFiK0AGWelyZBNEOZttM8v-uhEfj5Vp32YHPKF2T2_T4x-1-AcS05gKZmYqdzGyBevK0wk8725ng-zLvLeXA5OMX-sN1l42vj8v8_CO8vQryaS4znpbXZzW5_7y-9-udxZig7vsjs9h-SzDvR77BrU99mN4_6U_AG7mq2BD98IFldQctz0lp1tFq9xucIU5KqYuqb5js8_HXOyFOWLiQUi3vJmG-hDTcP9hgPFQqbnnkHDVxXvrd2p1moJ9IMOeP-QnRx-_Do_ivt_LMSFSsUm1hZww6C1wiviaX1VKWu9zH2eF6rKtPDBkjFKkiY6NSCyQia-CKbQICVyxUdsr17V8ITxDEQQvgxSQS5LUVoIuUrJERbK0gQRsbcDAO68C6Xh2i2I0a6DyyFcroXLXUTsA2E0lqQw2G0CSofrtcohe6MAiYUP2Brc53tAegL4xjzHfpg0Yi8JYdf5lI7K7GYmlcpYY7KIvWlLkDoj0IXvvRKwSxQYa1Jyf1IS1bCYZg9S5PppoHEZ0itlkVJhS16N2VSTTNtqWG2xTKJwRZLSJhF73And2OnMGimRYEbMTMRxMirTnHrxrQ0SjsNqLXLhiB0MkvuzXX8b9oNRuv8Bpaf_9_Rn7FbaqWScpvtsb7PewnMkdZvwotXmH2sfQ4A priority: 102 providerName: Springer Nature |
| Title | Are standardized conditions needed for correct CGM data interpretation in subjects at early stages of glucose intolerance? |
| URI | https://link.springer.com/article/10.1186/s13098-025-01579-x https://www.ncbi.nlm.nih.gov/pubmed/39844273 https://www.proquest.com/docview/3201591292 https://www.proquest.com/docview/3158764491 https://pubmed.ncbi.nlm.nih.gov/PMC11899435 https://dmsjournal.biomedcentral.com/counter/pdf/10.1186/s13098-025-01579-x https://doaj.org/article/0565060cab6e4690ae061e88477ff582 |
| UnpaywallVersion | publishedVersion |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: RBZ dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate | Ebsco customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: ABDBF dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: GX1 dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1758-5996 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: M48 dateStart: 20090901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: AAJSJ dateStart: 20091201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: C6C dateStart: 20091201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1758-5996 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067574 issn: 1758-5996 databaseCode: U2A dateStart: 20091201 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Zb9QwEB71kDgeEDeBshgJwQMNJI6T2A-o2q56CGkrhFhp3ywnccpKq-x2D7Htr2cmFw1UqC-JYjuJ7ZnxfLZnxgDvVG6kVJ7n4i1xRZBYV3lWuEEmA0QTRPMy2udZdDoSX8fheAsac9u6A5c3Tu3oPKnRYvppc3F5gAL_pRR4GX1e4jhMjmKczNDCWLmb9_MLlw6Wog3Y-pSNbdhFZcWJ8Yei3WhAuFwGakYlKl2KVNL41dz42Y7uKkP8_zuQX9Nkf1tZtlut9-Huupiby19mOr2mzY4fwoMahrJ-xTePYMsWj-HOsN5ofwJX_YVlzTLD5MpmDOfNWWXexQrUeJiCcBdTFzRkssHJkJGxKZt0jBjxkS3XCa31LJlZMUvhlOm753bJZjmrDebprdnU0hkf9uApjI6PfgxO3fqYBjcNubdyI2VxzhFFId6RJZTJc-xJI2ITx2mYB5FnEkX2LD73Iy6tF6TCN2ki08gKgXDzGewUs8K-ABZYL_FMlojQxiLzMmWTOOTkS2uzTCaeAx8bAuh5FY1Dl7MYGemKXBrJpUty6Y0Dh0SjtiRF0i4TZotzXQumRgBIMRZTk2BtIuUZiwjH4h_jGNshuQNviMK6ckttxwPdl1yEUkkZOPChLEE8ioROTe3YgE2i2FqdknudkijJaTe74SLdCIIOEKGFChkXa_K2zaY3yTqusLM1lvFDVGpCKN-B5xXTtY0OlBQCMaoDssOOnV7p5hSTn2WccexWpRBOO7DfcO6fev2v2_db7r4FlV7eolmv4B6v5NDlfA92Vou1fY1gcJX0YDsexz3YPTw6-_YdnwbRoFcurOD1ZOz3SnHH64j3fwNrA19A |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlE4IN4ECjUSiAON6nXsxD6gaimULe321Ep7M07ibVdaJdvNrvr4UfxGZvJqA1LFpacotvMYf-OZsT0zJuSDHlulNGM-XGJfBLHzNXPCD1IVgDWBmJfZPg_DwbH4OZKjFfK7iYVBt8pGJpaCOs0TXCPfCkBTSQ3aiW_Pznw8NQp3V5sjNCq22HeX5zBlK77sfQN8P3K--_1oZ-DXpwr4ieRs4YfagYkchhKuQIG247HU2orIRlEix0HIbKzR_aLHeyFXjgWJ6NkkVknohJC4AAoi_54ImMBc_dGoneCB7R2JJjBHhVsF6AcMYOPoHicj7V90lF95RsC_muCGKvzbTbPdq31I1pbZzF6e2-n0hjrcfUwe1XYs7VeM94SsuOwpuT-sd-qfkav-3NFmnWJy5VIKE--08g-jGahMKAF7GUrnKHPpzo8hRW9VOul4QcItLZYxLhYV1C6ow3zM-N4TV9B8TGuPe3wqnzo8JMRtPyfHd4LIC7Ka5Zl7RWjgWMxsGgvpIpGyVLs4khyDcV2aqph55HMDgJlV6TxMOQ1SoangMgCXKeEyFx75ihi1LTEVd1mQz09MPbINWJCYpDGxMfxNqJl1YCI5-GIUAR2Ke2QDETZVXGsrUExfcSGVVirwyKeyBYoUADqxdWQEkITJuTot1zstQRQk3eqGi0wtigpzPXA88r6txifRvS5z-RLa9CRoRSF0zyMvK6ZriQ60EgKMXI-oDjt2eqVbk01Oy0Tl0K1agz3ukc2Gc6__67Zu32y5-z9Qen071RtkbXA0PDAHe4f7b8gDXg1Hn_N1srqYL91bMCoX8btyJFPy665Fxx-a_YXG |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQKxU4VLxJKdRISBxo1DzsxD6hpbCUhVZIUKk3y04mZaVVstqHgP56ZvJiAwjBKYo9TmzPjOdzPDNh7JkurFI6CHy8OF_EDnwdgPDjXMWIJojndbbPs-TkXEwu5MVGFH_t7d4dSTYxDZSlqVwdzfOiUXGVHC1x5aXQsIgcz2SqfUSR20rqBLdf26PR5NOkW40RD6eiC5b5Y8uBQarz9v--Om-Yp19dJ_vz05vs-rqc2-9f7Wy2YaLGt9huiy35qBGG2-walHfYzml7en6XXY0WwLtvB9MryDmOOm98tniJZgxLEMNi6YLWQX789pSTBymfDjwT8ZYv144-4Cy5XXGgHMn03EtY8qrgrRc8tapmQD_ugJf32Pn4zefjE7_994KfyShY-YkG3EgkicQr8lnbopBaW5HaNM1kESeBdZqcVMIoTCIFQZyJ0GZOZQkIgRjyPtsqqxIeMh5D4AKbOyEhFXmQa3CpjChAFvJcucBjLzoGmHmTYsPUWxOVmIZdBtllanaZbx57RTzqKSk9dl1QLS5Nq20GUR0lTsysw97g_t8CwhbAN6YpjkNFHjsgDpsm1rRXcjNSkZBKKxV77HlNQWqOjM5sG62AQ6KEWQPK_QElqmc2rO6kyLTLw9LECLukRqiFPXnaV1NLcnkroVojTSjRUgmhQ489aISuH3SslRAIPD2mBuI4mJVhTTn9UicPx2nVGjGyxw47yf3Zr79N-2Ev3f_Apb3_e_oB2_n4emw-vDt7_4jdiBrt9KNon22tFmt4jLhv5Z60qv0D5adQKw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Are+standardized+conditions+needed+for+correct+CGM+data+interpretation+in+subjects+at+early+stages+of+glucose+intolerance%3F&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Dimova%2C+R&rft.au=Chakarova%2C+N&rft.au=Tankova%2C+T&rft.date=2025-01-22&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=17&rft.issue=1&rft.spage=29&rft_id=info:doi/10.1186%2Fs13098-025-01579-x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon |